NASDAQ: PMN
Promis Neurosciences Inc Stock Ownership - Who owns Promis Neurosciences?

Insider buying vs selling

Have Promis Neurosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neil CashmanChief Scientific Officer2025-02-1015,000$0.97
$14.60kBuy
Madge K. ShafmasterDirector2024-09-2470,000$1.30
$91.00kBuy
Madge K. ShafmasterDirector2024-09-2370,000$1.28
$89.67kBuy
Madge K. ShafmasterDirector2024-09-2060,000$1.25
$75.06kBuy

1 of 1

PMN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMN insiders and whales buy or sell their stock.

PMN Shareholders

What type of owners hold Promis Neurosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jeremy M. Sclar13.99%7,246,296$3.07MInsider
Abg Management Ltd11.69%6,058,738$2.57MInsider
Shaf Qic LLC10.01%5,184,760$2.20MInsider
Great Point Partners LLC5.11%2,645,128$1.12MInstitution
Michael S. Gordon4.79%2,483,362$1.05MInsider
19 Promis Title4.70%2,435,029$1.03MInsider
Armistice Capital LLC4.13%2,137,896$906.47kInstitution
Sphera Funds Management Ltd3.67%1,899,297$805.30kInstitution
Ally Bridge Group Ny LLC2.58%1,334,428$565.80kInstitution
Madge K. Shafmaster0.40%208,333$88.33kInsider

1 of 3

PMN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMN16.36%46.67%Net Buying
RLYB42.83%57.17%
SABS3.56%96.44%
LEXX11.75%4.18%Net BuyingNet Buying
ICU1.73%47.95%Net BuyingNet Buying

Promis Neurosciences Stock Ownership FAQ

Who owns Promis Neurosciences?

Promis Neurosciences (NASDAQ: PMN) is owned by 16.36% institutional shareholders, 46.67% Promis Neurosciences insiders, and 36.98% retail investors. Jeremy M. Sclar is the largest individual Promis Neurosciences shareholder, owning 7.25M shares representing 13.99% of the company. Jeremy M. Sclar's Promis Neurosciences shares are currently valued at $3.33M.

If you're new to stock investing, here's how to buy Promis Neurosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.